Q Synthesis LLC
  • Home
  • Systems Thinking
  • Implementation Science
  • About
  • Contact
  • Publications
  • Updates

Posters presented @ ASCO Quality Care Symposium

11/1/2022

 
Empowering pathologists to lead immuno-oncology (IO) biomarker testing in the community
Journal of Clinical Oncology
doi.org/10.1200/JCO.2022.40.28_suppl.348

Leveraging continuing education and implementation science approaches to improve the care of patients with myeloproliferative neoplasms
Journal of Clinical Oncology
doi.org/10.1200/JCO.2022.40.28_suppl.334

Reducing preventable ED visits in patients with advanced NSCLC: Collective insights from three cancer centers
Journal of Clinical Oncology
doi.org/10.1200/JCO.2022.40.28_suppl.337

​A mixed-methods study to identify key priorities around improving team-based care coordination for patients receiving combination IV and oral systemic anti-cancer therapy
Journal of Clinical Oncology
doi.org/10.1200/JCO.2022.40.28_suppl.052

Association of Community Cancer Centers key quality care recommendations for stage IB to IIIA non–small cell lung cancer
Journal of Clinical Oncology
doi.org/10.1200/JCO.2022.40.28_suppl.030


Comments are closed.

    Author

    @DrJosephKim
    Joseph Kim, MD, MPH, MBA, FACEHP is the Founder and President of Q Synthesis LLC.

    ​View Dr. Kim's bio on LinkedIn. 

    ​


    Sign up to receive updates:
Q Synthesis LLC
www.qsynthesis.com
  • Home
  • Systems Thinking
  • Implementation Science
  • About
  • Contact
  • Publications
  • Updates